News

UQ and African Network for Drugs and Diagnostics Innovation sign MOU to facilitate drug discovery in Africa

Published on: 11 April 2016

UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).

Australian and French researchers team up to discover new antibiotics

Published on: 8 April 2016

Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.

New research facility at the forefront of genomic engineering revolution

Published on: 31 March 2016

IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at UQ's St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.

Membrane Trafficking and Dynamics Symposium

Published on: 30 March 2016

You are invited to join us for a free half-day Membrane Trafficking and Dynamics Symposium on 18 April 2016 at IMB.

Breast cancer gene a key to unlocking new treatments

Published on: 23 March 2016

Researchers from The University of Queensland have identified a treatment target for aggressive forms of breast cancer.

World carbon dioxide emissions could rise more rapidly than expected

Published on: 10 March 2016

CO2 emissions and thus global warming could rise more quickly than expected, according to a new model by University of Queensland and Griffith University researchers.

UQ researchers unlocking mysteries of rare diseases

Published on: 29 February 2016

UQ researchers, including those at the IMB Centre for Rare Diseases Research, are working to find causes and treatments for some of the world’s rarest diseases – which collectively affect more than 1.2 million Australians.

What are rare diseases?

Published on: 29 February 2016

This year on Rare Disease Day, Associate Professor Carol Wicking, Director of the IMB Centre for Rare Diseases Research, explains what rare diseases are and why a co-ordinated approach to tackling rare diseases is needed.

Pancreatic cancer is four diseases, each with new treatment possibilities

Published on: 25 February 2016

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

Virtual 'toolset' frees researchers from IT stress

Published on: 23 February 2016

The director of The University of Queensland’s Research Computing Centre has been named the iTnews Education Chief Information Officer of the Year.

Global influencers at IMB

Published on: 22 February 2016

IMB is home to some of the world’s most influential scientific minds, measured by Thomson Reuters Highly Cited Researchers index. New group leader Professor Grant Montgomery was named in this prestigious index.

Australian-European alignment for new antibiotics

Published on: 9 February 2016

The Community for Open Antimicrobial Drug Discovery (CO-ADD) at The University of Queensland’s Institute for Molecular Bioscience (IMB) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.

Protagonist Therapeutics initiates Phase 1 study with oral peptide PTG-100

Published on: 11 January 2016

Protagonist Therapeutics, a spin-out company from IMB, has begun clinical trials with a novel drug candidate being investigated as a potential 'oral targeted therapy' for inflammatory bowel diseases.

ARC Fellow shows the way of the future

Published on: 16 December 2015

The Australian Research Council has awarded five new Future Fellows at The University of Queensland, including IMB's Dr Sonia Henriques whose research has huge potential in reducing global carbon emissions.

Enter the CO-ADD Chemistry Prize on Thinkable

Published on: 17 November 2015

The CO-ADD Chemistry Prize is an online competition open to all academic researchers and students worldwide, who can submit an abstract and an optional video on how chemistry can fight the war on superbugs and help find the next antibiotic. Entries close 15 January 2016.

UQ receives Grand Challenges Explorations grant for groundbreaking research in global health and development

Published on: 13 November 2015

The University of Queensland announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Research groups led by Professor Paul Young of the School of Chemistry and Molecular Biosciences, and Professor Matt Cooper at UQ’s Institute for Molecular Bioscience will pursue an innovative global health and development research project, titled Next-gen diagnostics for field-based surveillance of Wolbachia and arboviral infections in wild mosquitoes.

Experts meet to launch Antibiotic Awareness Week in Queensland

Published on: 13 November 2015

The University of Queensland has teamed up with the Queensland Department of Health to bring researchers and clinicians together to take action against antibiotic resistance.

NHMRC awards more than $11 million to IMB research

Published on: 9 November 2015

Research to investigate drug leads for cholesterol, antibiotics for drug-resistant bacteria, cardiovascular development, and inflammation are just some of the innovative projects at UQ’s Institute for Molecular Bioscience (IMB) to receive new funding from the National Health and Medical Research Council (NHMRC).

Queensland initiative to find new drug treatments secures state funding

Published on: 5 November 2015

An initiative to create new and potentially life-changing drugs has taken a step forward at The University of Queensland following an Advance Queensland funding agreement with the Queensland Government. The Queensland Emory Drug Discovery Initiative (QEDDI), to be based at UQ, will translate world-class academic drug discovery into candidates for clinical trials.

ARC invests $7M in IMB research

Published on: 30 October 2015

Researchers at UQ’s Institute for Molecular Bioscience have received $7 million from the Australian Research Council (ARC) to pursue discoveries in a range of health and agriculture areas. The grants will fund projects to develop biosensors that can talk to smartphones, more efficient algal biofactories, and pain treatments from venom.